Accretion Nutraveda Limited (BOM:544694)
India · Delayed Price · Currency is INR 283.00
+11.30 (4.16%)
At close: May 8, 2026
Accretion Nutraveda Revenue
In the fiscal year ending March 31, 2026, Accretion Nutraveda had annual revenue of 337.16M INR with 110.07% growth. Accretion Nutraveda had revenue of 196.50M in the quarter ending March 31, 2026, with 81.07% growth.
Revenue
337.16M
Revenue Growth
+110.07%
P/S Ratio
6.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 337.16M | 176.66M | 110.07% |
| Mar 31, 2025 | 160.49M | 109.80M | 216.62% |
| Mar 31, 2024 | 50.69M | 20.66M | 68.81% |
| Mar 31, 2023 | 30.03M | 24.18M | 413.23% |
| Mar 31, 2022 | 5.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 3.91B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.11B |
| Panchsheel Organics | 1.03B |
| Shree Ganesh Remedies | 1.01B |
| Resonance Specialties | 899.72M |
| Tyche Industries | 505.54M |